Skip to main content Accessibility help
×
Home
  • Print publication year: 2015
  • Online publication date: June 2015

2 - The endocrine glands and their hormones

Summary

The endocrine glands

The location of the human endocrine glands is shown in Figure 2.1. The pineal gland is a small gland lying deep between the cerebral cortex and the cerebellum at the posterior end of the third ventricle in the middle of the brain. The hypothalamus exerts some degree of control over most of the endocrine glands through the release of neurohormones, neuropeptides and neurotransmitters. The pituitary gland hangs from the bottom of the hypothalamus at the base of the brain and sits in a small cavity of bone above the roof of the mouth.

The thyroid gland is located in the neck and the small parathyroid glands are embedded in the surface of the thyroid. In the chest is the thymus gland, which is very important for the production of T lymphocytes that play a critical role in the immune response. The heart and lungs also act as endocrine glands that secrete hormones. The gastrointestinal (GI) tract, consisting of the stomach and intestines, is also an important source of hormones. The liver secretes several hormones such as somatomedin (also called IGF-1), important for growth. The adrenal glands are complex endocrine glands situated on top of the kidneys. The pancreas secretes hormones involved in regulating blood sugar levels and the kidney also produces hormone-like chemicals. The testes and ovaries produce gonadal hormones, or sex hormones, which, in addition to the maintenance of fertility and sex characteristics, have important effects on behavior. During pregnancy, the placenta acts as an endocrine gland. The endocrine glands occur in similar locations in all vertebrates. A large endocrine gland is fat (adipose tissue) which can be found beneath the skin (subcutaneous), in the abdominal cavity surrounding the heart and GI tract (see Figure 2.1), and within tissues such as liver and muscle. Fat secretes a variety of hormones called adipokines. Finally, two of the largest tissues in the body – skeletal muscle and bone – secrete factors that act in an endocrine fashion.

Related content

Powered by UNSILO
Ahima, R. S. and Lazar, M. A. (2008). “Adipokines and the peripheral and neural control of energy balance,” Mol Endocrinol 22, 1023–1031.
Bass, J. (2013). “Forever (FGF) 21,” Nat Med 19, 1090–1092.
Benarroch, E. E. (2007). “Enteric nervous system: functional organization and neurologic implications,” Neurol 69, 1953–1957.
Bikle, D. D. (2010). “Vitamin D: newly discovered actions require reconsideration of physiologic requirements,” Trends Endocrinol Metab 21, 375–384.
Bordicchia, M., Liu, D., Amri, E.-Z., Ailhaud, G., Dessi-Fulgheri, P., Zhang, C.et al. (2012). “Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes,” J Clin Invest 122, 1022–1036.
Boron, W. F. and Boulpaep, E. L. (2005). Medical Physiology, updated edn. (Philadelphia, PA: Elsevier Saunders), p. 1011.
Bostrum, P., Wu, J., Jedrychowski, M. P., Korde, L. Y., Ye, L., Lo, J. C.et al. (2012). “A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis,” Nature 481, 463–468.
Bradley, D. P., Kulstad, R. and Schoeller, D. A. (2010). “Exenatide and weight loss,” Nutrition 26, 243–249.
Charmandari, E., Tsigos, C. and Chrousos, G. (2005). “Endocrinology of the stress response,” Annu Rev Physiol 67, 259–284.
Chicurel, M. (2000). “Whatever happened to leptin?”Nature 404, 538–540.
Dhillo, W. S., Murphy, K. G. and Bloom, S. (2006). “Endocrinology: The next 60 years,” J Endocrinol 190, 7–10.
Frühbeck, G., Becerril, S., Sainz, N., Garrastachu, P. and Garcia-Velloso, M. J. (2009). “BAT: A new target for human obesity?”Trends Pharmacol Sci 30, 387–396.
Gardiner, J. V., Jayasena, C. N. and Bloom, S. R. (2008). “Gut hormones: A weight off your mind,” J Neuroendocrinol 20, 834–841.
Goldstein, A. L. and Badamchian, M. (2004). “Thymosins: Chemistry and biological properties in health and disease,” Expert Opin Biol Ther 4, 559–573.
Guntur, A. R. and Rosen, C. J. (2012). “Bone as an endocrine organ,” Endocr Pract 18, 758–762.
Hall, J., Roberts, R. and Vora, N. (2009). “Energy homoeostasis: The roles of adipose tissue-derived hormones, peptide YY and Ghrelin,” Obes Facts 2, 117–125.
Henry, B. A. and Clarke, I. J. (2008). “Adipose tissue hormones and the regulation of food intake,” J Neuroendocrinol 20, 842–849.
Huh, J. Y., Panagiotou, G., Mougios, V., Brinkoetter, M., Vamvini, M. T., Schneider, B. E.et al. (2012). “FNDG5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise,” Metabolism 61, 1725–1738.
Jelkmann, W. and Lundby, C. (2011). “Blood doping and its detection,” Blood 118, 2395–2404.
Kadmiel, M. and Cidlowski, J. A. (2013). “Glucocorticoid receptor signaling in health and disease,” Trends Pharmacol Sci 34, 518–530.
Karsenty, G. and Ferron, M. (2012). “The contribution of bone to whole-organism physiology,” Nature 481, 314–320.
Karsenty, G. and Oury, F. (2012). “Biology without walls: The novel endocrinology of bone,” Ann Rev Physiol 74, 87–105.
Kelly, D. P. (2012). “Irisin, light my fire,” Science 336, 42–43.
Khosla, S., Oursler, M. J. and Monroe, D. G. (2012). “Estrogen and the skeleton,” Trends Endocr Metab 23, 576–581.
LeBrasseur, N. K. (2012). “Building muscle, browning fat and preventing obesity by inhibiting myostatin,” Diabetologia 55, 13–17.
Lickert, H. (2013). “Betatrophin fuels β cell proliferation: First step toward regenerative therapy?”Cell Metab 18, 5–6.
Manson, J. E., Mayne, S. T. and Clinton, S. K. (2011). “Vitamin D and prevention of cancer – ready for prime time?”N Engl J Med 364, 1385–1387.
McPherron, A. C. and Lee, S.-J. (2002). “Suppression of body fat accumulation in myostatin-deficient mice,” J Clin Invest 109, 595–601.
Morton, G. J., Cummings, D. E., Baskin, D. G., Barsh, G. S. and Schwartz, M. W. (2006). “Central nervous system control of food intake and body weight,” Nature 443, 289–295.
Murphy, K. G. and Bloom, S. R. (2006). “Gut hormones and the regulation of energy homeostasis,” Nature 444, 854–859.
Myers, M. G., Heymsfield, S. B., Haft, C., Kahn, B. B., Laughlin, M., Leibel, R. L.et al. (2012). “Challenges and opportunities of defining clinical leptin resistance,” Cell Metab 15, 150–156.
Pedersen, B. K. and Febbraio, M. A. (2012). “Muscles, exercise and obesity: Skeletal muscle as a secretory organ,” Nat Rev Endocr 8, 457–465.
Potter, L. R., Abbey-Hosch, S. and Dickey, D. M. (2006). “Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions,” Endocr Revs 27, 47–72.
Raghow, R. (2013). “Betatrophin: A liver-derived hormone for pancreatic β-cell proliferation,” World J Diabet 4, 234–237.
Ritchie, R. H., Rosenkranz, A. C. and Kaye, D. M. (2009). “B-type natriuretic peptide: endogenous regulator of myocardial structure, biomarker and therapeutic target,” Curr Mol Med 9, 814–825.
Romijn, J. A., Corssmit, E. P., Havekes, L. M. and Pijl, H. (2008). “Gut-brain axis,” Curr Opin Clin Nutr Metab Care 11, 518–521.
Sam, A. H., Troke, R. C., Tan, T. M. and Bewick, G. A. (2012). “The role of the gut-brain axis in modulating food intake,” Neuropharmacol 63, 46–56.
Schwartz, D. R. and Lazar, M. A. (2011). “Human resistin: Found in translation from mouse to man,” Trends Endocrinol Metab 22, 259–265.
Stefan, N. and Häring, H.-U. (2013). “The role of hepatokines in metabolism,” Nat Rev Endocr 9, 144–152.
Strauss, J. F. and Barbieri, R.L. (2004). Yen and Jaffe's Reproductive Endocrinology, th edn. (Philadelphia, PA: Elsevier Saunders).
Unger, R. H. and Orci, L. (2010). “Paracrinology of islets and the paracrinopathy of diabetes,” Proc Natl Acad Sci USA 107, 16009–16012.
Van Lommel, A., Bolle, T., Fannes, W. and Lauweryns, J. M. (1999). “The pulmonary neuroendocrine system: The past decade,” Arch Histol Cytol 62, 1–16.
Villarroya, F. (2012). “Irisin, turning up the heat,” Cell Metab 15, 277–278.
Wallenius, V., Wallenius, K., Ahren, B., Rudling, M., Carlsten, H., Dickson, S. L.et al. (2002). “Interleukin-6 deficient mice develop mature-onset obesity,” Nat Med 8, 75–79.
Whittle, A. J. and Vidal-Puig, A. (2012). “NPs – heart hormones that regulate brown fat,” J Clin Invest 122, 804–807.
Widmaier, E. P., Raff, H. and Strang, K. T. (2010). Vander's Human Physiology: The Mechanisms of Body Function, th edn. (New York: McGraw-Hill).
Xiong, T., Qu, Y., Mu, D. and Ferriero, D. (2011). “Erythropoietin for neonatal brain injury: Opportunity and challenge,” Int J Dev Neurosci 29, 583–591.
Yates, D. (2013). “Signalling starvation,” Nat Rev Neurosci 14, 670–671.